{"id":"W2083791045","doi":"10.2165/00019053-200624080-00007","title":"Cost Effectiveness of Adding Ezetimibe to Atorvastatin Therapy in Patients Not at Cholesterol Treatment Goal in Canada","year":2006,"lang":"en","type":"article","venue":"PharmacoEconomics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University; Merck Canada Inc. (Canada)","funders":"","keywords":"Ezetimibe; Atorvastatin; Quality of Life Research; Health economics; Medicine; Public health; Ldl cholesterol; Pharmacotherapy; Cholesterol; Cost effectiveness; Intensive care medicine; Internal medicine; Risk analysis (engineering)","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007957565,0.0003944829,0.001044187,0.0006715373,0.001223531,0.001465902,0.001360028,0.00114478,0.002725767],"category_scores_gemma":[0.009620477,0.0003778786,0.001448379,0.002191407,0.0007012887,0.0004471716,0.0005333102,0.001308167,0.00009308857],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.07018042,"about_ca_system_score_gemma":0.06352785,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9822614,"about_ca_topic_score_gemma":0.987601,"domain_scores_codex":[0.998505,0.0003916843,0.0001160578,0.0001198529,0.0004433689,0.0004240237],"domain_scores_gemma":[0.9953537,0.001307028,0.0006203169,0.00006884769,0.001209781,0.001440242],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.06647678,0.00285538,0.698388,0.001544702,0.004164177,0.001652214,0.0005713424,0.04982392,0.001360872,0.003804188,0.02765566,0.1417028],"study_design_scores_gemma":[0.01239505,0.004031977,0.9146581,0.0004536064,0.005657822,0.0005693136,0.00155199,0.05295894,0.000701228,0.001173203,0.005646018,0.0002026158],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9780411,0.004559807,0.0001512619,0.007679485,0.0001283303,0.000167452,0.00295821,0.00003253175,0.00628172],"genre_scores_gemma":[0.9961879,0.001461925,0.0002707872,0.0006312104,0.00004354189,0.00002114533,0.0006766908,0.000005683069,0.0007011766],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07018042,"threshold_uncertainty_score":0.509197,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02107101357976402,"score_gpt":0.2939922897417853,"score_spread":0.2729212761620212,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}